Overview
Portfolio
More
Aescuvest
Frankfurt am Main, Germany
Facilitates impact‑driven investments in digital healthcare solutions by providing a fintech platform that matches investors with innovative health‑tech startups across Europe.
Portfolio
12+
Employees
15+
Founded
2014
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
Europe
Sources
Aescuvest
Facilitates impact‑driven investments in digital healthcare solutions by providing a fintech platform that matches investors with innovative health‑tech startups across Europe.
Portfolio
12+
Employees
15+
Founded
2014
AUM
N/A
Showing 9 of 9 matched portfolio companies
The startup offers a healthcare manufacturing data management platform that utilizes blockchain technology to ensure secure, immutable, and trackable data for autologous medicine production. By digitizing scheduling and quality approval processes, the platform enhances manufacturing efficiency, making these therapies more deliverable and affordable for patients.
Cardiolyse is a cloud-based ECG and HRV analytics platform that utilizes machine-learning algorithms to monitor heart health in real-time, providing personalized reports and detecting arrhythmias and other cardiac conditions. The platform predicts heart attacks and strokes up to two months in advance, enabling timely intervention for high-risk individuals.
Caresyntax provides an AI-powered, vendor-neutral surgical intelligence platform that integrates data from electronic medical records, video, and device metrics to enhance surgical workflow and decision-making. The platform improves patient outcomes, operational efficiency, and profitability by offering real-time support during procedures and comprehensive analytics for pre- and post-operative care.
Funding: $387.5M
Rough estimate of the amount of funding raised
Funding: $387.5M
Rough estimate of the amount of funding raised
DiaMonTech is developing a non-invasive blood glucose monitoring device that utilizes patented mid-infrared laser technology to detect glucose molecules in interstitial fluid without the need for test strips or invasive procedures. This device aims to provide accurate and painless glucose measurements within seconds, significantly improving diabetes management for users.
LillianCare addresses healthcare gaps in underserved regions by integrating modern healthcare professionals into primary care settings. The company adapts established international models to redistribute medical treatment responsibilities among physicians, Physician Assistants, and nurses. This approach aims to improve physician availability and accelerate patient treatment within the German healthcare system.
munevo develops munevo DRIVE, a smart head control system utilizing specialized smartglasses for intuitive power wheelchair operation. This assistive technology allows users with motor impairments to control their mobility devices effortlessly through head movements. The system provides enhanced independence and can be expanded with add-ons for controlling smartphones and smart home devices.
Neteera provides a contactless patient monitoring system that uses radar-based sensors to continuously track vital signs and activity. This FDA-cleared technology measures micro-movements to detect anomalies, aiding in early detection of potential issues like cardiac or respiratory deterioration. The system integrates real-time patient data into clinical workflows to enhance patient outcomes and optimize care delivery without requiring wearables.
Neurocare Group offers a digital therapy platform that utilizes transcranial magnetic stimulation (TMS) and neurofeedback technologies to enhance mental health treatment by personalizing therapy based on detailed patient assessments. This approach addresses the need for effective, evidence-based interventions for mental health disorders, leveraging the brain's neuroplasticity to promote lasting improvements in patient outcomes.
XO Life provides the brite TM platform, a unified digital hub connecting pharmaceutical and medical device manufacturers with patients and experts. This platform delivers continuous digital product and therapy support, aiming to improve patient adherence and treatment outcomes. Manufacturers gain access to standardized patient-reported outcomes and streamlined pharmacovigilance within a single application.
Funding: $14.7M
Rough estimate of the amount of funding raised
Funding: $14.7M
Rough estimate of the amount of funding raised
Showing 3 of 3 unmatched portfolio companies